Hepatitis B virus seroconversion in HIV-HBV coinfected patients treated with highly active antiretroviral therapy.

[1]  C. Katlama,et al.  Long‐term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus–infected patients , 1999, Hepatology.

[2]  M. Velasco,et al.  Resolution of chronic hepatitis B after ritonavir treatment in an HIV-infected patient. , 1999, The New England journal of medicine.

[3]  J. Carton,et al.  Lamivudine for chronic hepatitis B and HIV co-infection. , 1999, AIDS.

[4]  S. Lawrence,et al.  Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  M. French,et al.  Hepatitis C virus‐associated hepatitis following treatment of HIV‐infected patients with HIV protease inhibitors: an immune restoration disease? , 1998, AIDS.

[6]  V. Vullo,et al.  Acute clinical hepatitis in an HIV-seropositive hepatitis B carrier receiving protease inhibitor therapy. , 1998, AIDS.

[7]  J. Peña,et al.  Acute hepatitis in HIV-infected patients during ritonavir treatment. , 1998, AIDS.

[8]  T. Ferraro,et al.  Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy. , 1998, AIDS.

[9]  D. Cooper,et al.  Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor , 1997, The Lancet.

[10]  A. Detsky,et al.  Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B , 1993, Annals of Internal Medicine.